Earn up to 1.0 CME credit CHANGING COURSE: ANTICOAGULATION IN SECONDARY PREVENTION OF CAD THURSDAY, APRIL 26, 2018 11:45 am 12:15 pm Registration and Buffet Lunch 12:15 pm 1:15 pm CME Symposium MANCHESTER GRAND HYATT Harbor I, 2nd Floor 1 Market Place San Diego, CA 92101 REGISTER ONLINE This event is not part of the official SCAI 2018 Scientific Sessions as planned by the SCAI Program Committee. Imparting knowledge. Improving patient care. Medtelligence SM Jointly provided by the at Eisenhower and Medtelligence in collaboration with Postgraduate Institute for Medicine. Supported by an independent medical education grant from Janssen Scientific Affairs, LLC.
REGISTER ONLINE Faculty Deepak L. Bhatt, MD, FSCAI, Chair Executive Director Interventional Cardiovascular Programs Brigham and Women s Hospital Heart & Vascular Center Professor Harvard Medical School Boston, MA C. Michael Gibson, MD, FSCAI Professor of Medicine Harvard Medical School CEO and President Baim Institute and PERFUSE Study Group Founder, Editor-in-Chief Wikidoc.org Boston, MA Roxana Mehran, MD, MSCAI Professor of Medicine (Cardiology) and Population Health Science and Policy Director of Interventional Cardiovascular Research and Clinical Trials Zena and Michael A. Weiner Cardiovascular Institute Icahn School of Medicine at Mount Sinai New York, NY
CHANGING COURSE: ANTICOAGULATION IN SECONDARY PREVENTION OF CAD Program Overview This 1-hour, interactive symposium provides an opportunity for participants to evaluate the clinical issues and recent data regarding anticoagulation in patients with coronary artery disease (CAD). The introduction of non-vka oral anticoagulants (NOACs) into clinical practice has produced a wealth of data, changed guideline recommendations, and continues to push into new areas where an anticoagulation strategy may supplement or replace current thrombocardiology strategies for vascular protection from clot formation and embolization. Internationally renowned experts will evaluate the data, clinical implications, and recommendations in secondary prevention of CAD where an antiplatelet + anticoagulation management strategy has increasingly benefited patients by protecting against clot formation and embolization with NOACs, while keeping bleeding risks acceptable. Learning Objectives After completing this activity, the participant should be able to: Describe the rationale for combining an anticoagulant with antiplatelet therapy after stenting Relate the clinical implications of anticoagulation in CAD, based on recent data Utilize NOACs at the proper dose for patients with moderate or high risk of stroke, advising patients of the risks and benefits, and performing proper follow-up Apply guideline recommendations for secondary prevention of CAD after ACS or PCI and discuss the proposed changes that have been recommended based on recent data
CHANGING COURSE: ANTICOAGULATION IN SECONDARY PREVENTION OF CAD Target Audience This activity has been designed to meet the educational needs of Interventional/Invasive Cardiologists, Cardiologists, Fellows, and other Healthcare Professionals involved in the care of patients with coronary artery disease. Agenda 11:45 am Registration and Buffet Lunch 12:15 pm Welcome and Program Overview Deepak L. Bhatt, MD, FSCAI, Chair 12:20 Anticoagulation in CAD: Putting Data into Perspective C. Michael Gibson, MD, FSCAI 12:35 DAPT Duration and the Challenges of New Anticoagulation Data Roxana Mehran, MD, MSCAI 12:50 Faculty Discussion All Faculty 1:05 Q & A Faculty and Attendees 1:15 pm Adjourn
ATTENDANCE IS LIMITED PLEASE REGISTER ONLINE: For additional information, please contact Milly Marte at mmarte@medtelligence.net Physician Continuing Education Accreditation Statement This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the at Eisenhower and Medtelligence. The at Eisenhower is accredited by the ACCME to provide continuing medical education for physicians. Credit Designation The at Eisenhower designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Disclosure of Conflicts of Interest The at Eisenhower requires instructors, planners, managers and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to the at Eisenhower policy. The existence or absence of COI for everyone in a position to control content will be disclosed to participants prior to the start of each activity. Americans with Disabilities Act Event staff will be glad to assist you with any special needs (ie, physical, dietary, etc). Please contact Milly Marte prior to the live event at mmarte@medtelligence.net. Fee Information This activity is included in the Society for Cardiovascular Angiography and Interventions (SCAI) registration fee. Details are available here: scai.org/scai2018 Please note that unregistered guests cannot be accommodated. Registration will be available onsite.